HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are in good general health, confirmed through a screening check-up
- People who can read English, complete study assessments, and agree in writing and verbally to take part
People living with HIV (all HIV-positive groups):
- People who have tested positive for HIV-1
- People whose HIV is currently undetectable in their blood
- People who take their HIV medications consistently and as directed
People living with HIV who also use cannabis (PLWH + cannabis use group):
- People whose urine test shows recent cannabis use
- People who meet the clinical criteria for both cannabis use disorder and major depressive disorder, as assessed using a structured diagnostic interview (confirm with trial site)
Healthy comparison group (HIV-negative, no cannabis use):
- People who have tested negative for HIV-1
- People whose urine test shows no drug use
- People with no major physical or mental health diagnoses
HIV-positive only group (no cannabis use):
- People who have tested positive for HIV-1
- People whose urine test shows no drug use
- People with no major physical or mental health diagnoses
Cannabis use only group (HIV-negative):
- People who have tested negative for HIV-1
- People whose urine test shows recent cannabis use
- People who meet the clinical criteria for both cannabis use disorder and major depressive disorder, as assessed using a structured diagnostic interview (confirm with trial site)
Who may not be able to join:
- People who currently meet the criteria for a moderate or severe substance use disorder involving cocaine, alcohol, opioids, sedatives, or nicotine
- People with a current or past history of cocaine or opioid use disorder
- People with a history of any psychotic disorder
- People currently diagnosed with bipolar disorder or post-traumatic stress disorder (PTSD)
- People who are currently experiencing psychosis, suicidal thoughts, homicidal thoughts, or a manic episode
- People with significant underlying health conditions affecting the brain, kidneys, thyroid, or heart that could interfere with participation
- People currently taking medications known to affect stress hormone systems or immune function in the brain (confirm with trial site)
- People who are pregnant, breastfeeding, or using hormonal contraception that affects the body's cortisol stress response
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rajita Sinha, Ph.D., Yale University
Phone: 203-737-4791
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in cortisol levels; Change in adrenocorticotropic hormone (ACTH) levels; Change in pain stress
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.